Search Page

1

Cite

Share

New cholesterol guidelines: has Godot finally arrived?

Downs J, Good C. Downs J, et al. Among authors: good c. Ann Intern Med. 2014 Mar 4;160(5):354-5. doi: 10.7326/M13-2850. Ann Intern Med. 2014. PMID: 24473934 No abstract available.

Cite

Share

2

Cite

Share

Decrease the incentives to order lipid panels.

McConnell M, Downs JR, Good CB. McConnell M, et al. JAMA Intern Med. 2014 Mar;174(3):473. doi: 10.1001/jamainternmed.2013.12872. JAMA Intern Med. 2014. PMID: 24590082 No abstract available.

Cite

Share

3

Cite

Share

World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification.

Good CB, Kolb NR, Meyer M. Good CB, et al. Ann Intern Med. 2019 Apr 16;170(8):583. doi: 10.7326/L19-0068. Ann Intern Med. 2019. PMID: 30986841 No abstract available.

Cite

Share

4

Cite

Share

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.

Hernandez I, Good CB, Shrank WH, Gellad WF. Hernandez I, et al. JAMA. 2019 Apr 23;321(16):1627-1629. doi: 10.1001/jama.2019.2990. JAMA. 2019. PMID: 30907933 Free PMC article.

Cite

Share

5

Cite

Share

Lowering the P Value Threshold.

Hernandez I, Gellad WF, Good CB. Hernandez I, et al. JAMA. 2018 Sep 4;320(9):935. doi: 10.1001/jama.2018.8733. JAMA. 2018. PMID: 30193271 No abstract available.

Cite

Share

6

Cite

Share

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors.

San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. San-Juan-Rodriguez A, et al. JAMA Intern Med. 2019 May 1;179(5):713-716. doi: 10.1001/jamainternmed.2018.7656. JAMA Intern Med. 2019. PMID: 30776053 Free PMC article.

Cite

Share

7

Cite

Share

Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair.

Gellad WF, Good CB. Gellad WF, et al. JAMA Intern Med. 2016 Sep 1;176(9):1323-4. doi: 10.1001/jamainternmed.2016.3389. JAMA Intern Med. 2016. PMID: 27367570 No abstract available.

Cite

Share

8

Cite

Share

Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing.

Good CB, Gellad WF. Good CB, et al. JAMA Intern Med. 2016 Jan;176(1):63-4. doi: 10.1001/jamainternmed.2015.6068. JAMA Intern Med. 2016. PMID: 26524668 No abstract available.

Cite

Share

9

Cite

Share

Potential conflicts of interest for academic medical center leaders--reply.

Anderson TS, Good CB, Gellad WF. Anderson TS, et al. JAMA. 2014 Aug 6;312(5):558-9. doi: 10.1001/jama.2014.7578. JAMA. 2014. PMID: 25096702 No abstract available.

Cite

Share

10

Cite

Share

Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.

Radomski TR, Bixler FR, Zickmund SL, Roman KM, Thorpe CT, Hale JA, Sileanu FE, Hausmann LRM, Thorpe JM, Suda KJ, Stroupe KT, Gordon AJ, Good CB, Fine MJ, Gellad WF. Radomski TR, et al. J Gen Intern Med. 2018 Aug;33(8):1253-1259. doi: 10.1007/s11606-018-4374-1. Epub 2018 Mar 8. J Gen Intern Med. 2018. PMID: 29520747 Free PMC article.

Cite

Share